Tissue-Resident Memory CD8+ T Cells: Differentiation, Phenotypic Heterogeneity, Biological Function, Disease, and Therapy

Abstract

CD8+ tissue-resident memory T cells (TRM) are strategically located in peripheral tissues, enabling a rapid response to local infections, which is different from circulating memory CD8+ T cells. Their unique positioning makes them promising targets for vaccines designed to enhance protection at barrier sites and other organs. Recent studies have shown a correlation between CD8+ TRM cells and favorable clinical outcomes in various types of cancer, indicating their potential role in immune checkpoint blockade (ICB) therapies. However, the dual nature of CD8+ TRM cells presents challenges, as their inappropriate activation may lead to autoimmunity and chronic inflammatory conditions. This review highlights significant advancements in the field, focusing on the differentiation pathways and phenotypic heterogeneity of CD8+ TRM cells across different tissues and disease states. We also review their protective roles in various contexts and the implications for vaccine development against infections and treatment strategies for tumors. Overall, this comprehensive review outlines the common features of CD8+ TRM cell differentiation and biological functions, emphasizing their specific characteristics across diverse tissues and disease states, which can guide the design of therapies against infections and tumors while minimizing the risk of autoimmune diseases.

Keywords

autoimmune diseases / CD8 ⁺T _RM / ICB therapy / infection / tumor / vaccine

References

[1] D. G. R Ahmed, “Immunological Memory and Protective Immunity: Understanding Their Relation,” Science 272 (1996): 54–60.

[2] F. Sallusto, D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia, “Two Subsets of Memory T Lymphocytes With Distinct Homing Potentials and Effector Functions,” Nature 401 (1999): 708–712.

[3] T. Gebhardt, L. M. Wakim, L. Eidsmo, P. C. Reading, W. R. Heath, and F. R. Carbone, “Memory T Cells in Nonlymphoid Tissue That Provide Enhanced Local Immunity During Infection With Herpes Simplex Virus,” Nature Immunology 10 (2009): 524–530.

[4] D. Masopust, D. Choo, V. Vezys, et al., “Dynamic T Cell Migration Program Provides Resident Memory Within Intestinal Epithelium,” Journal of Experimental Medicine 207 (2010): 553–564.

[5] L. M. Wakim, N. Gupta, J. D. Mintern, and J. A. Villadangos, “Enhanced Survival of Lung Tissue-Resident Memory CD8(+) T Cells During Infection With Influenza Virus due to Selective Expression of IFITM3,” Nature Immunology 14 (2013): 238–245.

[6] H. Shin and A. Iwasaki, “A Vaccine Strategy That Protects Against Genital Herpes by Establishing Local Memory T Cells,” Nature 491 (2012): 463–467.

[7] M. Hofmann and H. Pircher, “E-Cadherin Promotes Accumulation of a Unique Memory CD8 T-Cell Population in Murine Salivary Glands,” PNAS 108 (2011): 16741–16746.

[8] K. A. Casey, K. A. Fraser, J. M. Schenkel, et al., “Antigen-Independent Differentiation and Maintenance of Effector-Like Resident Memory T Cells in Tissues,” Journal of Immunology 188 (2012): 4866–4875.

[9] L. M. Wakim, A. Woodward-Davis, and M. J. Bevan, “Memory T Cells Persisting Within the Brain After Local Infection Show Functional Adaptations to Their Tissue Of Residence,” PNAS 107 (2010): 17872–17879.

[10] M. Hofmann, A. Oschowitzer, S. R. Kurzhals, C. C. Krüger, and H. Pircher, “Thymus-Resident Memory CD8+T Cells Mediate Local Immunity,” European Journal of Immunology 43 (2013): 2295–2304.

[11] J. M. Schenkel, K. A. Fraser, and D. Masopust, “Cutting Edge: Resident Memory CD8 T Cells Occupy Frontline Niches in Secondary Lymphoid Organs,” Journal of Immunology 192 (2014): 2961–2964.

[12] S. W. Tse, I. A. Cockburn, H. Zhang, A. L. Scott, and F. Zavala, “Unique Transcriptional Profile of Liver-Resident Memory CD8+ T Cells Induced by Immunization With Malaria Sporozoites,” Genes and Immunity 14 (2013): 302–309.

[13] D. Fernandez-Ruiz, W. Y. Ng, L. E. Holz, et al., “Liver-Resident Memory CD8+ T Cells Form a Front-Line Defense Against Malaria Liver-Stage Infection,” Immunity 45 (2016): 889–902.

[14] S. N. Mueller and L. K. Mackay, “Tissue-Resident Memory T Cells: Local Specialists in Immune Defence,” Nature Reviews Immunology 16 (2016): 79–89.

[15] E. Rotrosen and T. S. Kupper, “Assessing the Generation of Tissue Resident Memory T Cells by Vaccines,” Nature Reviews Immunology 23 (2023): 655–665.

[16] J. J. Milner, C. Toma, B. Yu, et al., “Runx3 Programs CD8+ T Cell Residency in Non-Lymphoid Tissues and Tumours,” Nature 552 (2017): 253–257.

[17] S. L. Park, A. Buzzai, J. Rautela, et al., “Tissue-Resident Memory CD8+ T Cells Promote Melanoma–Immune Equilibrium in Skin,” Nature 565 (2018): 366–371.

[18] J. R. Webb, K. Milne, P. Watson, R. J. deLeeuw, and B. H. Nelson, “Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated With Increased Survival in High-Grade Serous Ovarian Cancer,” Clinical Cancer Research 20 (2014): 434–444.

[19] F. Djenidi, J. Adam, A. Goubar, et al., “CD8+CD103+ Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients,” Journal of Immunology 194 (2015): 3475–3486.

[20] B. Wang, S. Wu, H. Zeng, et al., “CD103 + Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder,” Journal of Urology 194 (2015): 556–562.

[21] Z.-Q. Wang, K. Milne, H. Derocher, J. R. Webb, B. H. Nelson, and P. H. Watson, “CD103 and Intratumoral Immune Response in Breast Cancer,” Clinical Cancer Research 22 (2016): 6290–6297.

[22] H. H. Workel, F. L. Komdeur, M. C. A. Wouters, et al., “CD103 Defines Intraepithelial CD8+ PD1+ Tumour-Infiltrating Lymphocytes of Prognostic Significance in Endometrial Adenocarcinoma,” European Journal of Cancer 60 (2016): 1–11.

[23] F. L. Komdeur, T. M. Prins, S. van de Wall, et al., “CD103+ Tumor-Infiltrating Lymphocytes Are Tumor-Reactive Intraepithelial CD8+ T Cells Associated With Prognostic Benefit and Therapy Response in Cervical Cancer,” OncoImmunology 6 (2017): e1338230.

[24] A. Losurdo, C. Scirgolea, G. Alvisi, et al., “Single-Cell Profiling Defines the Prognostic Benefit of CD39 High Tissue Resident Memory CD8+ T Cells in Luminal-Like Breast Cancer,” Communications Biology 4 (2021): 1117.

[25] P. Tallón de Lara, H. Castañón, M. Vermeer, et al., “CD39+PD-1+CD8+ T Cells Mediate Metastatic Dormancy in Breast Cancer,” Nature Communications 12 (2021): 769.

[26] Y. J. Lee, J. Y. Kim, S. H. Jeon, et al., “CD39+ Tissue-Resident Memory CD8 T Cells With a Clonal Overlap Across Compartments Mediate Antitumor Immunity in Breast Cancer,” Science Immunology 7 (2022): eabn8390.

[27] J. Clarke, B. Panwar, A. Madrigal, et al., “Single-Cell Transcriptomic Analysis of Tissue-Resident Memory T Cells in Human Lung Cancer,” Journal of Experimental Medicine 216 (2019): 2128–2149.

[28] E. Menares, F. Gálvez-Cancino, P. Cáceres-Morgado, et al., “Tissue-Resident Memory CD8+ T Cells Amplify Anti-Tumor Immunity by Triggering Antigen Spreading Through Dendritic Cells,” Nature Communications 10 (2019): 4401.

[29] R. Fonseca, L. K. Beura, C. F. Quarnstrom, et al., “Developmental Plasticity Allows Outside-In Immune Responses by Resident Memory T Cells,” Nature Immunology 21 (2020): 412–421.

[30] A. M. Luoma, S. B. Suo, Y. F. Wang, et al., “Tissue-Resident Memory and Circulating T Cells Are Early Responders to Pre-Surgical Cancer Immunotherapy,” Cell 185 (2022): 2918–2935.

[31] J. Edwards, J. S. Wilmott, J. Madore, et al., “CD103+ Tumor-Resident CD8+ T Cells Are Associated With Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment,” Clinical Cancer Research 24 (2018): 3036–3045.

[32] I. Siddiqui, K. Schaeuble, V. Chennupati, et al., “Intratumoral Tcf1+PD-1+CD8+ T Cells With Stem-Like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy,” Immunity 50 (2019): 195–211.

[33] B. C. Miller, D. R. Sen, R. Al Abosy, et al., “Subsets of Exhausted CD8+ T Cells Differentially Mediate Tumor Control and Respond to Checkpoint Blockade,” Nature Immunology 20 (2019): 326–336.

[34] C. S. Jansen, N. Prokhnevska, V. A. Master, et al., “An Intra-Tumoral Niche Maintains and Differentiates Stem-Like CD8 T Cells,” Nature 576 (2019): 465–470.

[35] A. Kallies, D. Zehn, and D. T. Utzschneider, “Precursor Exhausted T Cells: Key to Successful Immunotherapy?,” Nature Reviews Immunology 20 (2019): 128–136.

[36] Q. Huang, X. Wu, Z. Wang, et al., “The Primordial Differentiation of Tumor-Specific Memory CD8(+) T Cells as Bona Fide Responders to PD-1/PD-L1 Blockade in Draining Lymph Nodes,” Cell 185 (2022): 4049–4066.

[37] N. Asada, P. Ginsberg, N. Gagliani, H.-W. Mittrücker, and U. Panzer, “Tissue-Resident Memory T Cells in the Kidney,” Seminars in Immunopathology 44 (2022): 801–811.

[38] A. W. Ho and T. S. Kupper, “T Cells and the Skin: From Protective Immunity to Inflammatory Skin Disorders,” Nature Reviews Immunology 19 (2019): 490–502.

[39] S. N. Christo, M. Evrard, S. L. Park, et al., “Discrete Tissue Microenvironments Instruct Diversity in Resident Memory T Cell Function and Plasticity,” Nature Immunology 22 (2021): 1140–1151.

[40] J. T. Crowl, M. Heeg, A. Ferry, et al., “Tissue-Resident Memory CD8(+) T Cells Possess Unique Transcriptional, Epigenetic and Functional Adaptations to Different Tissue Environments,” Nature Immunology 23 (2022): 1121–1131.

[41] N. V. Gavil, M. C. Scott, E. Weyu, et al., “Chronic Antigen in Solid Tumors Drives a Distinct Program of T Cell Residence,” Science Immunology 8 (2023): eadd5976.

[42] K. Yang and A. Kallies, “Tissue-Specific Differentiation of CD8+ Resident Memory T Cells,” Trends in Immunology 42 (2021): 876–890.

[43] G. Marchesini Tovar, C. Gallen, and T. Bergsbaken, “CD8+ Tissue-Resident Memory T Cells: Versatile Guardians of the Tissue,” Journal of Immunology 212 (2024): 361–368.

[44] D. E. Ramirez, A. Mohamed, Y. H. Huang, and M. J. Turk, “In the Right Place at the Right Time: Tissue-Resident Memory T Cells in Immunity to Cancer,” Current Opinion in Immunology 83 (2023): 102338.

[45] N. V. Gavil, K. Cheng, and D. Masopust, “Resident Memory T Cells and Cancer,” Immunity 57 (2024): 1734–1751.

[46] P. A. Szabo, M. Miron, and D. L. Farber, “Location, Location, Location: Tissue Resident Memory T Cells in Mice and Humans,” Science Immunology 4 (2019): eaas9673.

[47] L. Kok, D. Masopust, and T. N. Schumacher, “The Precursors of CD8(+) Tissue Resident Memory T Cells: From Lymphoid Organs to Infected Tissues,” Nature Reviews Immunology 22 (2022): 283–293.

[48] D. Herndler-Brandstetter, H. Ishigame, R. Shinnakasu, et al., “KLRG1+ Effector CD8+ T Cells Lose KLRG1, Differentiate Into All Memory T Cell Lineages, and Convey Enhanced Protective Immunity,” Immunity 48 (2018): 716–729..

[49] S. Sheridan Brian, Q.-M. Pham, Y.-T. Lee, S. Cauley Linda, L. Puddington, and L. Lefrançois, “Oral Infection Drives a Distinct Population of Intestinal Resident Memory CD8+ T Cells With Enhanced Protective Function,” Immunity 40 (2014): 747–757.

[50] L. K. Mackay, A. Rahimpour, J. Z. Ma, et al., “The Developmental Pathway for CD103+CD8+ Tissue-Resident Memory T Cells of Skin,” Nature Immunology 14 (2013): 1294–1301.

[51] O. Gaide, R. O. Emerson, X. Jiang, et al., “Common Clonal Origin of Central and Resident Memory T Cells Following Skin Immunization,” Nature Medicine 21 (2015): 647–653.

[52] L. Kok, F. E. Dijkgraaf, J. Urbanus, et al., “A Committed Tissue-Resident Memory T Cell Precursor Within the Circulating CD8+ Effector T Cell Pool,” Journal of Experimental Medicine 217 (2020): e20191711.

[53] V. Mani, S. K. Bromley, T. Äijö, et al., “Migratory DCs Activate TGF-b to Precondition Naïve CD8+ T Cells for Tissue-Resident Memory Fate,” Science 366 (2019): eaav5728.

[54] S. Iborra, M. Martínez-López, C. Khouili Sofía, et al., “Optimal Generation of Tissue-Resident but Not Circulating Memory T Cells During Viral Infection Requires Crosspriming by DNGR-1 + Dendritic Cells,” Immunity 45 (2016): 847–860.

[55] I. Yu Chun, C. Becker, Y. Wang, et al., “Human CD1c+ Dendritic Cells Drive the Differentiation of CD103+ CD8+ Mucosal Effector T Cells via the Cytokine TGF-β” Immunity 38 (2013): 818–830.

[56] L. K. Mackay, E. Wynne-Jones, D. Freestone, et al., “T-Box Transcription Factors Combine With the Cytokines TGF-Beta and IL-15 to Control Tissue-Resident Memory T Cell Fate,” Immunity 43 (2015): 1101–1111.

[57] P. Hombrink, C. Helbig, R. A. Backer, et al., “Programs for the Persistence, Vigilance and Control of Human CD8+ Lung-Resident Memory T Cells,” Nature Immunology 17 (2016): 1467–1478.

[58] L. M. Wakim, A. Woodward-Davis, R. Liu, et al., “The Molecular Signature of Tissue Resident Memory CD8 T Cells Isolated From the Brain,” Journal of Immunology 189 (2012): 3462–3471.

[59] C. N. Skon, J. - Y. Lee, K. G. Anderson, D. Masopust, K. A. Hogquist, and S. C. Jameson, “Transcriptional Downregulation of S1pr1 Is Required for the Establishment of Resident Memory CD8+ T Cells,” Nature Immunology 14 (2013): 1285–1293.

[60] K. D. Zens, J. K. Chen, R. S. Guyer, et al., “Reduced Generation of Lung Tissue–Resident Memory T Cells During Infancy,” Journal of Experimental Medicine 214 (2017): 2915–2932.

[61] J. Laidlaw Brian, N. Zhang, D. Marshall Heather, et al., “CD4+ T Cell Help Guides Formation of CD103+ Lung-Resident Memory CD8+ T Cells During Influenza Viral Infection,” Immunity 41 (2014): 633–645.

[62] J. Wu, A. Madi, A. Mieg, et al., “T Cell Factor 1 Suppresses CD103+ Lung Tissue-Resident Memory T Cell Development,” Cell Reports 31 (2020): 107484.

[63] L. K. Mackay, M. Minnich, N. A. Kragten, et al., “Hobit and Blimp1 Instruct a Universal Transcriptional Program of Tissue Residency in Lymphocytes,” Science 352 (2016): 459–463.

[64] C. Li, B. Zhu, Y. M. Son, et al., “The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8+ T Cell Fitness and Functionality,” Immunity 51 (2019): 491–507.

[65] C. S. Boddupalli, S. Nair, S. M. Gray, et al., “ABC Transporters and NR4A1 Identify a Quiescent Subset of Tissue-Resident Memory T Cells,” Journal of Clinical Investigation 126 (2016): 3905–3916.

[66] A. N. Wein, S. R. McMaster, S. Takamura, et al., “CXCR6 Regulates Localization of Tissue-Resident Memory CD8 T Cells to the Airways,” Journal of Experimental Medicine 216 (2019): 2748–2762.

[67] E. Tu, C. P. Z. Chia, W. Chen, et al., “Cell Receptor-Regulated TGF-β Type I Receptor Expression Determines T Cell Quiescence and Activation,” Immunity 48 (2018): 745–759.

[68] H. Borges da Silva, C. Peng, H. Wang, et al., “Sensing of ATP via the Purinergic Receptor P2RX7 Promotes CD8+ TRM Cell Generation by Enhancing Their Sensitivity to the Cytokine TGF-β” Immunity 53 (2020): 158–171.

[69] S. K. Bromley, H. Akbaba, V. Mani, et al., “CD49a Regulates Cutaneous Resident Memory CD8+ T Cell Persistence and Response,” Cell Reports 32 (2020): 108085.

[70] E. C. Reilly, K. Lambert Emo, P. M. Buckley, et al., “Topham TRM Integrins CD103 and CD49a Differentially Support Adherence and Motility After Resolution of Influenza Virus Infection,” PNAS 117 (2020): 12306–12314.

[71] S. Cheuk, H. Schlums, I. Gallais Sérézal, et al., “CD49a Expression Defines Tissue-Resident CD8 + T Cells Poised for Cytotoxic Function in Human Skin,” Immunity 46 (2017): 287–300.

[72] R. T. Sowell, J. W. Goldufsky, M. Rogozinska, et al., “IL-15 Complexes Induce Migration of Resting Memory CD8 T Cells Into Mucosal Tissues,” Journal of Immunology 199 (2017): 2536–2546.

[73] R. R. Rao, Q. Li, K. Odunsi, and P. A. Shrikant, “The mTOR Kinase Determines Effector Versus Memory CD8+ T Cell Fate by Regulating the Expression of Transcription Factors T-Bet and Eomesodermin,” Immunity 32 (2010): 67–78.

[74] R. T. Sowell, M. Rogozinska, C. E. Nelson, V. Vezys, and A. L. Marzo, “Cutting Edge: Generation of Effector Cells That Localize to Mucosal Tissues and Form Resident Memory CD8 T Cells Is Controlled by mTOR,” Journal of Immunology 193 (2014): 2067–2071.

[75] A. C. Zhou, N. V. Batista, and T. H. Watts, “4-1BB Regulates Effector CD8 T Cell Accumulation in the Lung Tissue Through a TRAF1-, mTOR-, and Antigen-Dependent Mechanism to Enhance Tissue-Resident Memory T Cell Formation During Respiratory Influenza Infection,” Journal of Immunology 202 (2019): 2482–2492.

[76] L. E. Holz, J. E. Prier, D. Freestone, et al., “CD8(+) T Cell Activation Leads to Constitutive Formation of Liver Tissue-Resident Memory T Cells That Seed a Large and Flexible Niche in the Liver,” Cell Reports 25 (2018): 68–79.

[77] Y.-T. Lee, J. E Suarez-Ramirez, T. Wu, et al., “Environmental and Antigen Receptor-Derived Signals Support Sustained Surveillance of the Lungs by Pathogen-Specific Cytotoxic T Lymphocytes,” Journal of Virology 85 (2011): 4085–4094.

[78] L. Cheng and S. Becattini, “Local Antigen Encounter Promotes Generation of Tissue-Resident Memory T Cells in the Large Intestine,” Mucosal Immunology 17 (2024): 810–824.

[79] L. K. Mackay, A. T. Stock, J. Z. Ma, et al., “Long-Lived Epithelial Immunity by Tissue-Resident Memory T (TRM) Cells in the Absence of Persisting Local Antigen Presentation,” PNAS 109 (2012): 7037–7042.

[80] A. Pizzolla, T. H. O. Nguyen, J. M. Smith, et al., “Resident Memory CD8+ T Cells in the Upper Respiratory Tract Prevent Pulmonary Influenza Virus Infection,” Science Immunology 2 (2017): eaam6970.

[81] L. M. Wakim, J. Smith, I. Caminschi, M. H. Lahoud, and J. A. Villadangos, “Antibody-Targeted Vaccination to Lung Dendritic Cells Generates Tissue-Resident Memory CD8 T Cells That Are Highly Protective Against Influenza Virus Infection,” Mucosal Immunology 8 (2015): 1060–1071.

[82] J. J. Worthington, J. E. Klementowicz, and M. A. Travis, “TGFβ: A Sleeping Giant Awoken by Integrins,” Trends in Biochemical Sciences 36 (2011): 47–54.

[83] J. Mohammed, L. K. Beura, A. Bobr, et al., “Stromal Cells Control the Epithelial Residence of DCs and Memory T Cells by Regulated Activation of TGF-β” Nature Immunology 17 (2016): 414–421.

[84] T. Hirai, Y. Zenke, Y. Yang, et al., “Keratinocyte-Mediated Activation of the Cytokine TGF-β Maintains Skin Recirculating Memory CD8+ T Cells,” Immunity 50 (2019): 1249–1261.

[85] T. Hirai, Y. Yang, Y. Zenke, et al., “Competition for Active TGFβ Cytokine Allows for Selective Retention of Antigen-Specific Tissue-Resident Memory T Cells in the Epidermal Niche,” Immunity 54 (2021): 84–98.

[86] K. L. Cepek, S. K. Shaw, C. M. Parker, et al., “Adhesion Between Epithelial Cells and T Lymphocytes Mediated by E-Cadherin and the Alpha E Beta 7 Integrin,” Nature 372 (1994): 190–193.

[87] N. Zhang and J. Bevan Michael, “Transforming Growth Factor-β Signaling Controls the Formation and Maintenance of Gut-Resident Memory T Cells by Regulating Migration and Retention,” Immunity 39 (2013): 687–696.

[88] D. A. Walsh, H. Borges da Silva, L. K. Beura, et al., “The Functional Requirement for CD69 in Establishment of Resident Memory CD8(+) T Cells Varies With Tissue Location,” Journal of Immunology 203 (2019): 946–955.

[89] H. A. McNamara, Y. Cai, M. V. Wagle, et al., “Up-Regulation of LFA-1 Allows Liver-Resident Memory T Cells to Patrol and Remain in the Hepatic Sinusoids,” Science Immunology 2 (2017): eaaj1996.

[90] R. Tieu, Q. Zeng, D. Zhao, et al., “Tissue-Resident Memory T Cell Maintenance During Antigen Persistence Requires Both Cognate Antigen and Interleukin-15,” Science Immunology 8 (2023): eadd8454.

[91] S. L. Park, S. N. Christo, A. C. Wells, et al., “Divergent Molecular Networks Program Functionally Distinct CD8+ Skin-Resident Memory T Cells,” Science 382 (2023): 1073–1079.

[92] J. M. Schenkel, K. A. Fraser, K. A. Casey, et al., “IL-15–Independent Maintenance of Tissue-Resident and Boosted Effector Memory CD8 T Cells,” Journal of Immunology 196 (2016): 3920–3926.

[93] T. Adachi, T. Kobayashi, E. Sugihara, et al., “Hair Follicle–Derived IL-7 and IL-15 Mediate Skin-Resident Memory T Cell Homeostasis and Lymphoma,” Nature Medicine 21 (2015): 1272–1279.

[94] N. K. Minkah, B. K. Wilder, A. A. Sheikh, et al., “Innate Immunity Limits Protective Adaptive Immune Responses Against Pre-Erythrocytic Malaria Parasites,” Nature Communications 10 (2019): 3950.

[95] Y. M. Son, I. S. Cheon, Y. Wu, et al., “Tissue-Resident CD4+ T Helper Cells Assist the Development of Protective Respiratory B and CD8+ T Cell Memory Responses,” Science Immunology 6 (2021): eabb6852.

[96] C. Ferreira, L. Barros, M. Baptista, et al., “Type 1 Treg Cells Promote the Generation of CD8+ Tissue-Resident Memory T Cells,” Nature Immunology 21 (2020): 766–776.

[97] Y. Pan, T. Tian, C. O. Park, et al., “Survival of Tissue-Resident Memory T Cells Requires Exogenous Lipid Uptake and Metabolism,” Nature 543 (2017): 252–256.

[98] H. Frizzell, R. Fonseca, S. N. Christo, et al., “Organ-Specific Isoform Selection of Fatty Acid-Binding Proteins in Tissue-Resident Lymphocytes,” Science Immunology 5 (2020): eaay9283.

[99] G. Li, S. Srinivasan, L. Wang, et al., “TGF-β-Dependent Lymphoid Tissue Residency of Stem-Like T Cells Limits Response to Tumor Vaccine,” Nature Communications 13 (2022): 6043.

[100] Y. Huang, L. Zhou, H. Zhang, L. Zhang, X. Xi, and Y. Sun, “BMDCs Induce the Generation of the CD103+CD8+ Tissue-Resident Memory T Cell Subtype, Which Amplifies Local Tumor Control in the Genital Tract,” Cellular Immunology 374 (2022): 104502.

[101] E. Segura, M. Touzot, A. Bohineust, et al., “Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation,” Immunity 38 (2013): 336–348.

[102] P. Michea, F. Noël, E. Zakine, et al., “Adjustment of Dendritic Cells to the Breast-Cancer Microenvironment Is Subset Specific,” Nature Immunology 19 (2018): 885–897.

[103] M. Binnewies, A. M. Mujal, J. L. Pollack, et al., “Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4(+) T Cell Immunity,” Cell 177 (2019): 556–571.

[104] G. Bakdash, S. I. Buschow, M. A. J. Gorris, et al., “Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines,” Cancer Research 76 (2016): 4332–4346.

[105] P. Bourdely, G. Anselmi, K. Vaivode, et al., “Transcriptional and Functional Analysis of CD1c+ Human Dendritic Cells Identifies a CD163+ Subset Priming CD8+CD103+ T Cells,” Immunity 53 (2020): 335–352.

[106] R. Muthuswamy, A. J. R. McGray, S. Battaglia, et al., “CXCR6 by Increasing Retention of Memory CD8+ T Cells in the Ovarian Tumor Microenvironment Promotes Immunosurveillance and Control of Ovarian Cancer,” Journal for ImmunoTherapy of Cancer 9 (2021): e003329.

[107] S. Karaki, C. Blanc, T. Tran, et al., “CXCR6 Deficiency Impairs Cancer Vaccine Efficacy and CD8+ Resident Memory T-Cell Recruitment in Head and Neck and Lung Tumors,” Journal for ImmunoTherapy of Cancer 9 (2021): e001948.

[108] B. Wang, Y. Wang, X. Sun, et al., “CXCR6 is required for antitumor efficacy of intratumoral CD8+ T cell,” Journal for ImmunoTherapy of Cancer 9 (2021).

[109] L. S. Christian, L. Wang, B. Lim, et al., “Resident Memory T Cells in Tumor-Distant Tissues Fortify Against Metastasis Formation,” Cell Reports 35 (2021): 109118.

[110] J. L. Vella, A. Molodtsov, C. V. Angeles, B. R. Branchini, M. J. Turk, and Y. H. Huang, “Dendritic Cells Maintain Anti-Tumor Immunity by Positioning CD8 Skin-Resident Memory T Cells,” Life Science Alliance 4 (2021): e202101056.

[111] R. Peng, S. Liu, W. You, et al., “Gastric Microbiome Alterations Are Associated With Decreased CD8+ Tissue-Resident Memory T Cells in the Tumor Microenvironment of Gastric Cancer,” Cancer Immunology Research 10 (2022): 1224–1240.

[112] M. Di Pilato, R. Kfuri-Rubens, J. N. Pruessmann, et al., “CXCR6 Positions Cytotoxic T Cells to Receive Critical Survival Signals in the Tumor Microenvironment,” Cell 184 (2021): 4512–4530.

[113] I. Liikanen, C. Lauhan, S. Quon, et al., “Hypoxia-Inducible Factor Activity Promotes Antitumor Effector Function and Tissue Residency by CD8+T Cells,” Journal of Clinical Investigation 131 (2021): e143729.

[114] M. Feng, X. Liu, X. Hao, et al., “Fatty Acids Support the Fitness and Functionality of Tumor-Resident CD8+ T Cells by Maintaining SCML4 Expression,” Cancer Research 83 (2023): 3368–3384.

[115] M. Reina-Campos, M. Heeg, K. Kennewick, et al., “Metabolic Programs of T Cell Tissue Residency Empower Tumour Immunity,” Nature 621 (2023): 179–187.

[116] B. Zitti, E. Hoffer, W. Zheng, et al., “Human Skin-Resident CD8+ T Cells Require RUNX2 and RUNX3 for Induction of Cytotoxicity and Expression of the Integrin CD49a,” Immunity 56 (2023): 1285–1302.

[117] Y. H. Lin, H. G. Duong, A. E. Limary, et al., “Small Intestine and Colon Tissue-Resident Memory CD8+ T Cells Exhibit Molecular Heterogeneity and Differential Dependence on Eomes,” Immunity 56 (2023): 207–223.

[118] J. Fang, J. Lei, B. He, et al., “Decoding the Transcriptional Heterogeneity, Differentiation Lineage, Clinical Significance in Tissue-Resident Memory CD8 T Cell of the Small Intestine by Single-Cell Analysis,” Journal of Translational Medicine 22 (2024): 203.

[119] M. E. B FitzPatrick, N. M. Provine, L. C. Garner, et al., “Human Intestinal Tissue-Resident Memory T Cells Comprise Transcriptionally and Functionally Distinct Subsets,” Cell Reports 34 (2021): 108661.

[120] T. Bergsbaken and M. J. Bevan, “Proinflammatory Microenvironments Within the Intestine Regulate the Differentiation of Tissue-Resident CD8+ T Cells Responding to Infection,” Nature Immunology 16 (2015): 406–414.

[121] T. B. MJB and P. J. Fink, “Local Inflammatory Cues Regulate Differentiation and Persistence of CD8+ Tissue-Resident Memory T Cells,” Cell Reports 19 (2017): 114–124.

[122] H. Y. Fung, M. Teryek, A. D. Lemenze, and T. Bergsbaken, “CD103 Fate Mapping Reveals That Intestinal CD103–Tissue-Resident Memory T Cells Are the Primary Responders to Secondary Infection,” Science Immunology 7 (2022): eabl9925.

[123] M. von Hoesslin, M. Kuhlmann, G. P. de Almeida, et al., “Secondary Infections Rejuvenate the Intestinal CD103+ Tissue-Resident Memory T Cell Pool,” Science Immunology 7 (2022): eabp9553.

[124] H. Y. Fung, A. M. Espinal, M. Teryek, A. D. Lemenze, and T. Bergsbaken, “STAT4 Increases the Phenotypic and Functional Heterogeneity of Intestinal Tissue-Resident Memory T Cells,” Mucosal Immunology 16 (2023): 250–263.

[125] L. Wang, S. Mishra, K. K.-H. Fan, et al., “T-Bet Deficiency and Hic1 Induction Override TGF-β-Dependency in the Formation of CD103+ Intestine-Resident Memory CD8+ T Cells,” Cell Reports 43 (2024): 114258.

[126] J. H. Kim, J. W. Han, Y. J. Choi, et al., “Functions of Human Liver CD69+CD103-CD8+ T Cells Depend on HIF-2α Activity in Healthy and Pathologic Livers,” Journal of Hepatology 72 (2020): 1170–1181.

[127] L. J. Pallett, J. Davies, E. J. Colbeck, et al., “IL-2 High Tissue-Resident T Cells in the Human Liver: Sentinels for Hepatotropic Infection,” Journal of Experimental Medicine 214 (2017): 1567–1580.

[128] T. Peng, K. Phasouk, E. Bossard, et al., “Distinct Populations of Antigen Specific Tissue Resident CD8 T Cells in Human Cervix Mucosa,” JCI Insight 6 (2021): e149950.

[129] N. S. Kurd, Z. He, T. L. Louis, et al., “Early Precursors and Molecular Determinants of Tissue Resident Memory CD8+ T Lymphocytes Revealed by Single-Cell RNA Sequencing,” Science Immunology 5 (2020): eaaz6894.

[130] J. J. Milner, C. Toma, Z. He, et al., “Heterogenous Populations of Tissue-Resident CD8+ T Cells Are Generated in Response to Infection and Malignancy,” Immunity 52 (2020): 7.

[131] B. S. Boland, Z. He, M. S. Tsai, et al., “Heterogeneity and Clonal Relationships of Adaptive Immune Cells in Ulcerative Colitis Revealed by Single-Cell Analyses,” Science Immunology 5 (2020): eabb4432.

[132] J. M. Schenkel, K. A. Fraser, V. Vezys, and D. Masopust, “Sensing and Alarm Function of Resident Memory CD8(+) T Cells,” Nature Immunology 14 (2013): 509–513.

[133] L. M. Wakim, J. Waithman, N. van Rooijen, W. R. Heath, and F. R. Carbone, “Dendritic Cell-Induced Memory T Cell Activation in Nonlymphoid Tissues,” Science 319 (2008): 198–202.

[134] X. Jiang, R. A. Clark, L. Liu, A. J. Wagers, R. C. Fuhlbrigge, and T. S. Kupper, “Skin Infection Generates Non-Migratory Memory CD8+ T(RM) Cells Providing Global Skin Immunity,” Nature 483 (2012): 227–231.

[135] K. Steinbach, I. Vincenti, M. Kreutzfeldt, et al., “Brain-Resident Memory T Cells Represent an Autonomous Cytotoxic Barrier to Viral Infection,” Journal of Experimental Medicine 213 (2016): 1571–1587.

[136] J. M. Schenkel, K. A. Fraser, L. K. Beura, et al., “Resident Memory CD8 T Cells Trigger Protective Innate and Adaptive Immune Responses,” Science 346 (2014): 98–101.

[137] S. Ariotti, M. A. Hogenbirk, F. E. Dijkgraaf, et al., “Skin-Resident Memory CD8+ T Cells Trigger a State of Tissue-Wide Pathogen Alert,” Science 346 (2014): 101–105.

[138] M. Enamorado, S. Iborra, E. Priego, et al., “Enhanced Anti-Tumour Immunity Requires the Interplay Between Resident and Circulating Memory CD8+ T Cells,” Nature Communications 8 (2017): 16073.

[139] B. T. Malik, K. T. Byrne, J. L. Vella, et al., “Resident Memory T Cells in the Skin Mediate Durable Immunity to Melanoma,” Science Immunology 2 (2017): eaam6346.

[140] B. Clarke, A. V. Tinker, C.-H. Lee, et al., “Intraepithelial T Cells and Prognosis in Ovarian Carcinoma: Novel Associations With Stage, Tumor Type, and BRCA1 Loss,” Modern Pathology 22 (2009): 393–402.

[141] F. P. Canale, M. C. Ramello, N. Núñez, et al., “CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+ T Cells,” Cancer Research 78 (2018): 115–128.

[142] A. Chow, F. Z. Uddin, M. Liu, et al., “The Ectonucleotidase CD39 Identifies Tumor-Reactive CD8+ T Cells Predictive of Immune Checkpoint Blockade Efficacy in Human Lung Cancer,” Immunity 56 (2023): 93–106.

[143] T. Duhen, R. Duhen, R. Montler, et al., “Co-Expression of CD39 and CD103 Identifies Tumor-Reactive CD8 T Cells in Human Solid Tumors,” Nature Communications 9 (2018): 2724.

[144] S. N. Marcus Buggert, O. de Gonzalo Salgado-Montes, B. Bengsch, et al., “Identification and Characterization of HIV-Specific Resident Memory CD8+ T Cells in Human Lymphoid Tissue,” Science Immunology 3 (2018): eaar4526.

[145] L. K. Beura, S. Wijeyesinghe, E. A. Thompson, et al., “T Cells in Nonlymphoid Tissues Give Rise to Lymph-Node-Resident Memory T Cells,” Immunity 48 (2018): 327–338.

[146] A. K. Molodtsov, N. Khatwani, J. L. Vella, et al., “Resident Memory CD8+ T Cells in Regional Lymph Nodes Mediate Immunity to Metastatic Melanoma,” Immunity 54 (2021): 2117–2132.

[147] T. Wu, Y. Hu, Y.-T. Lee, et al., “Lung-Resident Memory CD8 T Cells (TRM) Are Indispensable for Optimal Cross-Protection Against Pulmonary Virus Infection,” Journal of Leukocyte Biology 95 (2014): 215–224.

[148] P. Gilchuk, M. Hill Timothy, C. Guy, et al., “A Distinct Lung-Interstitium-Resident Memory CD8 + T Cell Subset Confers Enhanced Protection to Lower Respiratory Tract Infection,” Cell Reports 16 (2016): 1800–1809.

[149] A. Jozwik, M. S. Habibi, A. Paras, et al., “RSV-Specific Airway Resident Memory CD8+ T Cells and Differential Disease Severity After Experimental Human Infection,” Nature Communications 6 (2015): 10224.

[150] J. Grau-Expósito, N. Sánchez-Gaona, N. Massana, et al., “Peripheral and Lung Resident Memory T Cell Responses Against SARS-CoV-2,” Nature Communications 12 (2021): 3010.

[151] M.-S. Rha, G. Kim, S. Lee, et al., “SARS-CoV-2 Spike-Specific Nasal-Resident CD49a+CD8+ Memory T Cells Exert Immediate Effector Functions With Enhanced IFN-γ Production,” Nature Communications 15 (2024): 8355.

[152] A. H. E Roukens, C. R. Pothast, M. König, et al., “Prolonged Activation of Nasal Immune Cell Populations and Development of Tissue-Resident SARS-CoV-2-Specific CD8+ T Cell Responses Following COVID-19,” Nature Immunology 23 (2021): 23–32.

[153] N. P. Goplen, Y. Wu, Y. M. Son, et al., “Tissue-Resident CD8+ T Cells Drive Age-Associated Chronic Lung Sequelae After Viral Pneumonia,” Science Immunology 5 (2020): eabc4557.

[154] B. Slütter, N. Van Braeckel-Budimir, and G. Abboud, “Dynamics of Influenza-Induced Lung-Resident Memory T Cells Underlie Waning Heterosubtypic Immunity,” Science Immunology 2 (2017): eaag2031.

[155] J. Michael Stolley, T. S. Johnston, A. G. Soerens, et al., “Retrograde Migration Supplies Resident Memory T Cells to Lung-Draining LN After Influenza Infection,” Journal of Experimental Medicine 217 (2020): e20192197.

[156] S. L. Hayward, C. D. Scharer, E. K. Cartwright, et al., “Environmental Cues Regulate Epigenetic Reprogramming of Airway-Resident Memory CD8+ T Cells,” Nature Immunology 21 (2020): 309–320.

[157] N. Van Braeckel-Budimir, S. M. Varga, V. P. Badovinac, and J. T. Harty, “Repeated Antigen Exposure Extends the Durability of Influenza-Specific Lung-Resident Memory CD8+ T Cells and Heterosubtypic Immunity,” Cell Reports 24 (2018): 3374–3382.

[158] Z. Wang, S. Wang, N. P. Goplen, et al., “PD-1hi CD8+ Resident Memory T Cells Balance Immunity and Fibrotic Sequelae,” Science Immunology 4 (2019): eaaw1217.

[159] S. Ariotti, J. B. Beltman, G. Chodaczek, et al., “Tissue-Resident Memory CD8 + T Cells Continuously Patrol Skin Epithelia to Quickly Recognize Local Antigen,” PNAS 109 (2012): 19739–19744.

[160] A. Zaid, L. K. Mackay, A. Rahimpour, et al., “Persistence of Skin-Resident Memory T Cells Within an Epidermal Niche,” PNAS 111 (2014): 5307–5312.

[161] J. Zhu, T. Peng, C. Johnston, et al., “Immune Surveillance by CD8αα+ Skin-Resident T Cells in Human Herpes Virus Infection,” Nature 497 (2013): 494–497.

[162] R. Watanabe, A. Gehad, C. Yang, et al., “Human Skin Is Protected by Four Functionally and Phenotypically Discrete Populations of Resident and Recirculating Memory T Cells,” Science Translational Medicine 7 (2015): 279ra39.

[163] F. E. Dijkgraaf, T. R. Matos, M. Hoogenboezem, et al., “Tissue Patrol by Resident Memory CD8+ T Cells in Human Skin,” Nature Immunology 20 (2019): 756–764.

[164] T. A. Landrith, S. Sureshchandra, A. Rivera, et al., “CD103+ CD8 T Cells in the Toxoplasma-Infected Brain Exhibit a Tissue-Resident Memory Transcriptional Profile,” Frontiers in Immunology 8 (2017): 335.

[165] R. Aguilar-Valenzuela, J. Netland, Y. J. Seo, M. J. Bevan, A. Grakoui, and M. S. Suthar, “Dynamics of Tissue-Specific CD8+ T Cell Responses During West Nile Virus Infection,” Journal of Virology 92 (2018): e00014-18.

[166] S. L. Urban, I. J. Jensen, Q. Shan, et al., “Peripherally Induced Brain Tissue–Resident Memory CD8+ T Cells Mediate Protection Against CNS Infection,” Nature Immunology 21 (2020): 938–949.

[167] J. Smolders, K. M. Heutinck, N. L. Fransen, et al., “Tissue-Resident Memory T Cells Populate the Human Brain,” Nature Communications 9 (2018): 4593.

[168] M. Philip and A. Schietinger, “CD8+ T Cell Differentiation and Dysfunction in Cancer,” Nature Reviews Immunology 22 (2021): 209–223.

[169] C. M. Anadon, X. Yu, K. Hänggi, et al., “Ovarian Cancer Immunogenicity Is Governed by a Narrow Subset of Progenitor Tissue-Resident Memory T Cells,” Cancer Cell 40 (2022): 545–557.

[170] P. Savas, B. Virassamy, C. Ye, et al., “Single-Cell Profiling of Breast Cancer T Cells Reveals a Tissue-Resident Memory Subset Associated With Improved Prognosis,” Nature Medicine 24 (2018): 986–993.

[171] A.-P. Ganesan, J. Clarke, O. Wood, et al., “Tissue-Resident Memory Features Are Linked to the Magnitude of Cytotoxic T Cell Responses in Human Lung Cancer,” Nature Immunology 18 (2017): 940–950.

[172] C. A. Hartana, E. Ahlén Bergman, A. Broomé, et al., “Tissue-Resident Memory T Cells Are Epigenetically Cytotoxic With Signs of Exhaustion in Human Urinary Bladder Cancer,” Clinical and Experimental Immunology 194 (2018): 39–53.

[173] J. Han, Y. Zhao, K. Shirai, et al., “Resident and Circulating Memory T Cells Persist for Years in Melanoma Patients With Durable Responses to Immunotherapy,” Nature Cancer 2 (2021): 300–311.

[174] L. Chen and Z. Shen, “Tissue-Resident Memory T Cells and Their Biological Characteristics in the Recurrence of Inflammatory Skin Disorders,” Cellular and Molecular Immunology 17 (2019): 64–75.

[175] K. Boniface, C. Jacquemin, A.-S. Darrigade, et al., “Vitiligo Skin Is Imprinted With Resident Memory CD8 T Cells Expressing CXCR3,” Journal of Investigative Dermatology 138 (2018): 355–364.

[176] J. M. Richmond, J. P. Strassner, M. Rashighi, et al., “Resident Memory and Recirculating Memory T Cells Cooperate to Maintain Disease in a Mouse Model of Vitiligo,” Journal of Investigative Dermatology 139 (2019): 769–778.

[177] I. Gallais Sérézal, E. Hoffer, B. Ignatov, et al., “A Skewed Pool of Resident T Cells Triggers Psoriasis-Associated Tissue Responses in Never-Lesional Skin From Patients With Psoriasis,” Journal of Allergy and Clinical Immunology 143 (2019): 1444–1454.

[178] O. Boyman, H. P. Hefti, C. Conrad, B. J. Nickoloff, M. Suter, and F. O. Nestle, “Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-Alpha,” Journal of Experimental Medicine 199 (2004): 731–736.

[179] J. M. Richmond, J. P. Strassner, L. Zapata Jr., et al., “Antibody Blockade of IL-15 Signaling Has the Potential to Durably Reverse Vitiligo,” Science Translational Medicine 10 (2018): eaam7710.

[180] F. Arnold, L. Kupferschmid, P. Weissenborn, et al., “Tissue-Resident Memory T Cells Break Tolerance to Renal Autoantigens and Orchestrate Immune-Mediated Nephritis,” Cellular and Molecular Immunology 21 (2024): 1066–1081.

[181] L. Li, W. Tang, Y. Zhang, et al., “Targeting Tissue-Resident Memory CD8+ T Cells in the Kidney Is a Potential Therapeutic Strategy to Ameliorate Podocyte Injury and Glomerulosclerosis,” Molecular Therapy 30 (2022): 2746–2759.

[182] Z. You, Y. Li, Q. Wang, et al., “The Clinical Significance of Hepatic CD69+CD103+CD8+ Resident-Memory T Cells in Autoimmune Hepatitis,” Hepatology 74 (2021): 847–863.

[183] H. Kefalakes, X. J. Horgan, M. K. Jung, et al., “Liver-Resident Bystander CD8+ T Cells Contribute to Liver Disease Pathogenesis in Chronic Hepatitis D Virus Infection,” Gastroenterology 161 (2021): 1567–1583.

[184] M. Dudek, D. Pfister, S. Donakonda, et al., “Auto-Aggressive CXCR6+ CD8 T Cells Cause Liver Immune Pathology in NASH,” Nature 592 (2021): 444–449.

[185] Y. Koda, T. Teratani, P.-S. Chu, et al., “CD8+ Tissue-Resident Memory T Cells Promote Liver Fibrosis Resolution by Inducing Apoptosis of Hepatic Stellate Cells,” Nature Communications 12 (2021).

[186] M. E. S MOF, T. J. Connors, P. Dogra, et al., “Generation and Persistence of Human Tissue-Resident Memory T Cells in Lung Transplantation,” Science Immunology 4 (2019): eaav5581.

[187] I. Khodor, R. T Abou-Daya, D. Zhao, et al., “Resident Memory T Cells Form During Persistent Antigen Exposure Leading to Allograft Rejection,” Science Immunology 6 (2021): eabc8122.

[188] K. de Leur, M. Dieterich, D. A. Hesselink, et al., “Characterization of Donor and Recipient CD8+ Tissue-Resident Memory T Cells in Transplant Nephrectomies,” Scientific Reports 9 (2019): 5984.

[189] Z. Wang, Y. He, W. Wang, et al., “A Novel “Prime and Pull” Strategy Mediated by the Combination of Two Dendritic Cell-Targeting Designs Induced Protective Lung Tissue-Resident Memory T Cells Against H1N1 Influenza Virus Challenge,” Journal of Nanobiotechnology 21 (2023): 479.

[190] L. Zayou, S. Prakash, N. R. Dhanushkodi, et al., “A Multi-Epitope/CXCL11 Prime/Pull Coronavirus Mucosal Vaccine Boosts the Frequency and the Function of Lung-Resident Memory CD4+ and CD8+ T Cells and Enhanced Protection Against COVID-19-Like Symptoms and Death Caused by SARS-CoV-2 Infection,” Journal of Virology 97 (2023): e0109623.

[191] T. M. Olsen, B. C. Stone, V. Chuenchob, and S. C. Murphy, “Prime-and-Trap Malaria Vaccination to Generate Protective CD8(+) Liver-Resident Memory T Cells,” Journal of Immunology 201 (2018): 1984–1993.

[192] A. Gola, D. Silman, A. A. Walters, et al., “Prime and Target Immunization Protects Against Liver-Stage Malaria in Mice,” Science Translational Medicine 10 (2018): eaap9128.

[193] K. D. Zens, J. K. Chen, and D. L. Farber, “Vaccine-Generated Lung Tissue–Resident Memory T Cells Provide Heterosubtypic Protection to Influenza Infection,” JCI Insight 1 (2016): e85832.

[194] C. Perdomo, U. Zedler, A. A. Kühl, et al., “Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations Against Tuberculosis,” MBio 7 (2016): e01686-16.

[195] K. M. Morabito, T. R. Ruckwardt, A. J. Redwood, S. M. Moin, D. A. Price, and B. S. Graham, “Intranasal Administration of RSV Antigen-Expressing MCMV Elicits Robust Tissue-Resident Effector and Effector Memory CD8+ T Cells in the Lung,” Mucosal Immunology 10 (2017): 545–554.

[196] A. O. Hassan, N. M. Kafai, I. P. Dmitriev, et al., “A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts Against SARS-CoV-2,” Cell 183 (2020): 169–184.

[197] S. Afkhami, M. R. D’Agostino, A. Zhang, et al., “Respiratory Mucosal Delivery of Next-Generation COVID-19 Vaccine Provides Robust Protection Against Both Ancestral and Variant Strains of SARS-CoV-2,” Cell 185 (2022): 896–915.

[198] A. S. HMN, F. Nuhu, N. Jahan, et al., “Expansion of Cytotoxic Tissue-Resident CD8+ T Cells and CCR6+CD161+ CD4+ T Cells in the Nasal Mucosa Following mRNA COVID-19 Vaccination,” Nature Communications 13 (2022): 3357.

[199] L. E. Holz, Y. C. Chua, M. N. de Menezes, et al., “Glycolipid-Peptide Vaccination Induces Liver-Resident Memory CD8(+) T Cells That Protect Against Rodent Malaria,” Science Immunology 5 (2020): eaaz8035.

[200] S. L. Park, A. Zaid, J. L. Hor, et al., “Local Proliferation Maintains a Stable Pool of Tissue-Resident Memory T Cells After Antiviral Recall Responses,” Nature Immunology 19 (2018): 183–191.

[201] S. J. Hobbs and J. C. Nolz, “Targeted Expansion of Tissue-Resident CD8+ T Cells to Boost Cellular Immunity in the Skin,” Cell Reports 29 (2019): 2990–2997.

[202] T. R. Matos, A. Gehad, J. E. Teague, et al., “Central Memory T Cells Are the Most Effective Precursors of Resident Memory T Cells in Human Skin,” Science Immunology 7 (2022): eabn1889.

[203] F. M. Behr, A. Beumer-Chuwonpad, N. A. M. Kragten, T. H. Wesselink, R. Stark, and K. van Gisbergen, “Circulating Memory CD8(+) T Cells Are Limited in Forming CD103(+) Tissue-Resident Memory T Cells at Mucosal Sites After Reinfection,” European Journal of Immunology 51 (2021): 151–166.

[204] B. Davies, J. E. Prier, C. M. Jones, T. Gebhardt, F. R. Carbone, and L. K. Mackay, “Cutting Edge: Tissue-Resident Memory T Cells Generated by Multiple Immunizations or Localized Deposition Provide Enhanced Immunity,” Journal of Immunology 198 (2017): 2233–2237.

[205] F. C. Knight, P. Gilchuk, A. Kumar, et al., “Mucosal Immunization With a pH-Responsive Nanoparticle Vaccine Induces Protective CD8+ Lung-Resident Memory T Cells,” ACS Nano 13 (2019): 10939–10960.

[206] L. Matarazzo and P. J. G. Bettencourt, “mRNA Vaccines: A New Opportunity for Malaria, Tuberculosis and HIV,” Frontiers in Immunology 14 (2023): 1172691.

[207] F. Rizvi, E. Everton, A. R. Smith, et al., “Murine Liver Repair via Transient Activation of Regenerative Pathways in Hepatocytes Using Lipid Nanoparticle-Complexed Nucleoside-Modified mRNA,” Nature Communications 12 (2021): 613.

[208] M. Ganley, L. E. Holz, J. J. Minnell, et al., “mRNA Vaccine Against Malaria Tailored for Liver-Resident Memory T Cells,” Nature Immunology 24 (2023): 1487–1498.

[209] S. Nakamae, S. Miyagawa, K. Ogawa, et al., “Induction of Liver-Resident Memory T Cells and Protection at Liver-Stage Malaria by mRNA-Containing Lipid Nanoparticles,” Frontiers in Immunology 14 (2023): 1116299.

[210] A. M Valencia-Hernandez, T. Zillinger, Z. Ge, et al., “Complexing CpG Adjuvants With Cationic Liposomes Enhances Vaccine-Induced Formation of Liver T(RM) Cells,” Vaccine 41 (2023): 1094–1107.

[211] I. Caminschi, M. H. Lahoud, A. Pizzolla, and L. M. Wakim, “Zymosan by-Passes the Requirement for Pulmonary Antigen Encounter in Lung Tissue-Resident Memory CD8+ T Cell Development,” Mucosal Immunology 12 (2019): 403–412.

[212] M. Nizard, H. Roussel, M. O. Diniz, et al., “Induction of Resident Memory T Cells Enhances the Efficacy of Cancer Vaccine,” Nature Communications 8 (2017): 15221.

[213] A. MacKerracher, A. Sommershof, and M. Groettrup, “PLGA Particle Vaccination Elicits Resident Memory CD8 T Cells Protecting From Tumors and Infection,” European Journal of Pharmaceutical Sciences 175 (2022): 106209.

[214] E. T. I. van der Gracht, M. J. A. Schoonderwoerd, S. van Duikeren, et al., “Adenoviral Vaccines Promote Protective Tissue-Resident Memory T Cell Populations Against Cancer,” Journal for ImmunoTherapy of Cancer 8 (2020): e001133.

[215] I.-Y. Jung, E. Noguera-Ortega, R. Bartoszek, et al., “Tissue-Resident Memory CAR T Cells With Stem-Like Characteristics Display Enhanced Efficacy Against Solid and Liquid Tumors,” Cell Reports Medicine 4 (2023): 101053.

[216] S. Corgnac, I. Malenica, L. Mezquita, et al., “CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched With Tc17,” Cell Reports Medicine 1 (2020): 100127.

[217] C. Krishna, R. G. DiNatale, F. Kuo, et al., “Single-Cell Sequencing Links Multiregional Immune Landscapes and Tissue-Resident T Cells in ccRCC to Tumor Topology and Therapy Efficacy,” Cancer Cell 39 (2021): 662–677.

[218] K. Jin, Y. Yu, H. Zeng, et al., “CD103+CD8+ Tissue-Resident Memory T Cell Infiltration Predicts Clinical Outcome and Adjuvant Therapeutic Benefit in Muscle-Invasive Bladder Cancer,” British Journal of Cancer 126 (2022): 1581–1588.

[219] P. Gueguen, C. Metoikidou, T. Dupic, et al., “Contribution of Resident and Circulating Precursors to Tumor-Infiltrating CD8+ T Cell Populations in Lung Cancer,” Science Immunology 6 (2021): eabd5778.

[220] M. Barsch, H. Salié, A. E. Schlaak, et al., “T-Cell Exhaustion and Residency Dynamics Inform Clinical Outcomes in Hepatocellular Carcinoma,” Journal of Hepatology 77 (2022): 397–409.

[221] G. Oliveira, A. M. Egloff, A. B. Afeyan, et al., “Preexisting Tumor-Resident T Cells With Cytotoxic Potential Associate With Response to Neoadjuvant Anti–PD-1 in Head and Neck Cancer,” Science Immunology 8 (2023): eadf4968.

[222] B. Virassamy, F. Caramia, P. Savas, et al., “Intratumoral CD8+ T Cells With A Tissue-Resident Memory Phenotype Mediate Local Immunity and Immune Checkpoint Responses in Breast Cancer,” Cancer Cell 41 (2023): 585–601.

[223] J. Gungabeesoon, N. A Gort-Freitas, M. Kiss, et al., “A Neutrophil Response Linked to Tumor Control in Immunotherapy,” Cell 186 (2023): 1448–1464.

[224] F. M. Behr, L. Parga-Vidal, N. A. M. Kragten, et al., “Tissue-Resident Memory Cd8+ T Cells Shape Local and Systemic Secondary T Cell Responses,” Nature Immunology 21 (2020): 1070–1081.

[225] C. Sievers, M. Craveiro, J. Friedman, et al., “Phenotypic Plasticity and Reduced Tissue Retention of Exhausted Tumor-Infiltrating T Cells Following Neoadjuvant Immunotherapy in Head and Neck Cancer,” Cancer Cell 41 (2023): 887–902.

[226] A. A. Tarun Gupta, L. Chloe Hyun-Jung, B. Rosana Ottakandathil, et al., “Tracking In Situ Checkpoint Inhibitor-Bound Target T Cells in Patients With Checkpoint-Induced Colitis,” Cancer Cell 42 (2024): 797–814.

[227] S. C. Sasson, S. M. Slevin, V. T. F. Cheung, et al., “Interferon-Gamma–Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor–Colitis,” Gastroenterology 161 (2021): 1229–1244.

[228] M. J. M. van Eijs, J. J. M. ter Linde, M. J. D. Baars, et al., “Highly Multiplexed Spatial Analysis Identifies Tissue-Resident Memory T Cells As Drivers of Ulcerative and Immune Checkpoint Inhibitor Colitis,” Iscience 26 (2023): 107891.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.